Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Vial 1 Vial x 25 U/0.5 ml |
|
||
|
Vial 1 Vial x 50 U/ml |
|
66549 | 22179 |
Indications
Active pre-exposure prophylaxis against disease caused by Hepatitis A virus in persons 2 years and older. Primary immunization should be given at least 2 weeks prior to expected exposure to HIV.
See prescribing information for full details.
Contra-Indications
Hypersensitivity to any component of the vaccine.
Special Precautions
Will not prevent hepatitis caused by infectious agents other than hepatitis A virus, bleeding disorders in people who are at risk of hemorrhage, acute infection or febrile illness, pregnancy and lactation.
Side Effects
No serious vaccine-related adverse experiences were observed during clinical trials.
Drug interactions
None reported.
